Apogee Therapeutics (APGE) Proxy filing summary

Voting matters and shareholder proposals

• Election of three Class III directors for terms expiring in 2029, with nominees Mark C. McKenna, Jennifer Fox, and William (BJ) Jones, Jr. recommended by the board.

• Advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement.

• Ratification of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2026.

• Additional business may be addressed if properly brought before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends all three director nominees for election to serve until 2029.

Executive compensation and say-on-pay

• Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.